XML 21 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Equity Statement - USD ($)
$ in Millions
Total
Common Stock, $0.10 Par Value
Capital In Excess of Par
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Non-controlling Interest
Beginning balance at Dec. 31, 2019 $ 2,561.4 $ 18.6 $ 829.7 $ 4,188.8 $ (412.0) $ (2,092.8) $ 29.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 206.2     206.2      
Stock compensation plans 16.5   10.5     6.0  
Shares for benefit plan trust (0.4)         (0.4)  
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax [1] 1.6       1.6    
Net hedging gains (losses) and other, net of income tax [1] 17.2       17.2    
Foreign currency translation adjustments [1] (35.4)       (33.6)   (1.8)
Dividends (57.1)     (57.1)      
Repurchases of common stock (7.3)         (7.3)  
Ending balance at Mar. 31, 2020 2,702.7 18.6 840.2 4,337.9 (426.8) (2,094.5) 27.3
Beginning balance at Dec. 31, 2019 2,561.4 18.6 829.7 4,188.8 (412.0) (2,092.8) 29.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 503.3            
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax 12.0            
Ending balance at Sep. 30, 2020 2,968.4 18.6 854.7 4,519.3 (357.9) (2,090.2) 23.9
Beginning balance at Mar. 31, 2020 2,702.7 18.6 840.2 4,337.9 (426.8) (2,094.5) 27.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 185.0     184.4     0.6
Stock compensation plans 8.2   6.3     1.9  
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax [1] 1.4       1.4    
Net hedging gains (losses) and other, net of income tax [1] (10.5)       (10.5)    
Foreign currency translation adjustments [1] 21.5       20.7   0.8
Dividends (57.2)     (57.2)      
Repurchases of common stock (0.2)         (0.2)  
Ending balance at Jun. 30, 2020 2,850.9 18.6 846.5 4,465.1 (415.2) (2,092.8) 28.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 112.1     111.4     0.7
Stock compensation plans 13.4   10.8     2.6  
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax [1] 9.0       9.0    
Net hedging gains (losses) and other, net of income tax [1] 7.2       7.2    
Foreign currency translation adjustments [1] 41.7       41.1   0.6
Dividends [1] (57.2)     (57.2)      
Acquisitions of noncontrolling interests [2] (7.4)   (2.6)       (4.8)
Distributions to noncontrolling interests (1.3)           (1.3)
Ending balance at Sep. 30, 2020 2,968.4 18.6 854.7 4,519.3 (357.9) (2,090.2) 23.9
Beginning balance at Dec. 31, 2020 2,984.2 18.6 860.2 4,506.4 (282.2) (2,141.2) 22.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 183.2     182.6     0.6
Stock compensation plans 9.6   5.2     4.4  
Shares for benefit plan trust (0.1)         (0.1)  
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax [3] 4.3       4.3    
Net hedging gains (losses) and other, net of income tax [3] 44.6       44.6    
Foreign currency translation adjustments [3] (49.8)       (49.5)   (0.3)
Dividends (62.0)     (62.0)      
Repurchases of common stock (82.7)         (82.7)  
Ending balance at Mar. 31, 2021 3,031.3 18.6 865.4 4,627.0 (282.8) (2,219.6) 22.7
Beginning balance at Dec. 31, 2020 2,984.2 18.6 860.2 4,506.4 (282.2) (2,141.2) 22.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 546.8            
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax 13.2            
Ending balance at Sep. 30, 2021 3,057.0 18.6 874.6 4,864.9 (284.2) (2,442.5) 25.6
Beginning balance at Mar. 31, 2021 3,031.3 18.6 865.4 4,627.0 (282.8) (2,219.6) 22.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 203.2     202.9     0.3
Stock compensation plans 5.6   5.1     0.5  
Shares for benefit plan trust 2.5         2.5  
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax [3] 4.3       4.3    
Net hedging gains (losses) and other, net of income tax [3] (40.9)       (40.9)    
Foreign currency translation adjustments [3] 15.3       14.9   0.4
Dividends (62.0)     (62.0)      
Repurchases of common stock (25.2)         (25.2)  
Ending balance at Jun. 30, 2021 3,134.1 18.6 870.5 4,767.9 (304.5) (2,241.8) 23.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 160.4     157.9     2.5
Stock compensation plans 4.1   4.1        
Shares for benefit plan trust (0.7)         (0.7)  
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax [1] 4.6       4.6    
Net hedging gains (losses) and other, net of income tax [1] 42.2       42.2    
Foreign currency translation adjustments [1] (26.8)       (26.5)   (0.3)
Dividends (60.9)     (60.9)      
Repurchases of common stock (200.0)         (200.0)  
Ending balance at Sep. 30, 2021 $ 3,057.0 $ 18.6 $ 874.6 $ 4,864.9 $ (284.2) $ (2,442.5) $ 25.6
[1] See condensed consolidated statements of comprehensive income (loss).
[2] In July 2020, we purchased the remaining 49 percent ownership interest in our Indonesia joint venture, PT Bina Guna Kimia ("BGK"), for $7.4 million which increased our ownership from 51 percent to 100 percent.
[3] See condensed consolidated statements of comprehensive income (loss).